Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Mar 20:13:937-943.
doi: 10.2147/COPD.S156130. eCollection 2018.

Lack of association between airflow limitation and recurrence of venous thromboembolism among cancer patients with pulmonary embolism

Sun Hye Shin  1 , Danbee Kang  2 , Juhee Cho  2 , Haseong Chang  3 , Min Sun Kim  3 , Su Yeon Lee  3 , Hyun Lee  1 , Hojoong Kim  1 , Duk-Kyung Kim  3 , Eun Kyoung Kim #  3 , Hye Yun Park #  1
Affiliations

Lack of association between airflow limitation and recurrence of venous thromboembolism among cancer patients with pulmonary embolism

Sun Hye Shin et al. Int J Chron Obstruct Pulmon Dis. .

Abstract

Background: COPD is a well-known risk factor for venous thromboembolism (VTE) development. However, recent data showed that it was not associated with VTE recurrence risk, which excluded cancer patients. This study investigated the association of airflow limitation and VTE recurrence in cancer patients with pulmonary embolism (PE).

Methods: This is a retrospective cohort study of cancer patients with newly diagnosed PE at a university hospital. PE was confirmed using contrast-enhanced computed tomography scan. Airflow limitation was defined as pre-bronchodilator forced expiratory volume in 1 second (FEV1)/forced vital capacity (FVC) <0.7 within 2 years of PE diagnosis. VTE recurrence was defined as a composite of recurrence as PE or deep vein thrombosis or both.

Results: Among 401 cancer patients with newly diagnosed PE, spirometry-based airflow limitation was observed in 126 (31.4%) patients. Half of the patients had lung cancer, which was more common in the group with airflow limitation (65.1% vs 42.9%, p < 0.001). Symptomatic PE was present in less than half (45.4%) of the cases, and 62.6% of patients were treated for PE. During the median follow-up period of 9.7 months, VTE recurred in 49 (12.2%) patients. Compared with patients without airflow limitation, those with airflow limitation did not have an increased risk of VTE recurrence in univariate or multivariate analyses (adjusted hazard ratio, 1.29 [95% CI 0.68, 2.45]).

Conclusion: The presence of airflow limitation did not increase the risk of VTE recurrence in cancer patients with PE. Prospective studies are needed to validate this finding.

Keywords: cancer; chronic obstructive pulmonary disease; pulmonary embolism; recurrence; venous thromboembolism.

PubMed Disclaimer

Conflict of interest statement

Disclosure The authors report no conflicts of interest in this work.

Figures

Figure 1
Figure 1
A consort diagram of the study population. Abbreviations: PE, pulmonary embolism; PFT, pulmonary function test.
Figure 2
Figure 2
Cumulative VTE recurrence in cancer patients with PE according to airflow limitation. Abbreviations: AL, airflow limitation; PE, pulmonary embolism; VTE, venous thromboembolism.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Heit JA. Epidemiology of venous thromboembolism. Nat Rev Cardiol. 2015;12(8):464–474. - PMC - PubMed
    1. Goldhaber SZ, Visani L, De Rosa M. Acute pulmonary embolism: clinical outcomes in the International Cooperative Pulmonary Embolism Registry (ICOPER) Lancet. 1999;353(9162):1386–1389. - PubMed
    1. Becattini C, Agnelli G, Pesavento R, et al. Incidence of chronic thromboembolic pulmonary hypertension after a first episode of pulmonary embolism. Chest. 2006;130(1):172–175. - PubMed
    1. Heit JA, Mohr DN, Silverstein MD, Petterson TM, O’Fallon WM, Melton LJ., 3rd Predictors of recurrence after deep vein thrombosis and pulmonary embolism: a population-based cohort study. Arch Intern Med. 2000;160(6):761–768. - PubMed
    1. Carrier M, Le Gal G, Wells PS, Rodger MA. Systematic review: case-fatality rates of recurrent venous thromboembolism and major bleeding events among patients treated for venous thromboembolism. Ann Intern Med. 2010;152(9):578–589. - PubMed

MeSH terms